Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer

Introduction: Although demographic heterogeneity in the management of patients with non-muscle invasive bladder tumor (NMIBT) is an important factor, there are only minimal evidence-based recommendations that adjust for patient age and gender. The relationship and impact of age and gender on the rec...

Full description

Bibliographic Details
Main Authors: Huseyin Kocan, Mustafa Kadihasanoglu
Format: Article
Language:English
Published: Pensoft Publishers 2021-04-01
Series:Folia Medica
Subjects:
Online Access:https://foliamedica.bg/article/53234/download/pdf/
_version_ 1818879247181152256
author Huseyin Kocan
Mustafa Kadihasanoglu
author_facet Huseyin Kocan
Mustafa Kadihasanoglu
author_sort Huseyin Kocan
collection DOAJ
description Introduction: Although demographic heterogeneity in the management of patients with non-muscle invasive bladder tumor (NMIBT) is an important factor, there are only minimal evidence-based recommendations that adjust for patient age and gender. The relationship and impact of age and gender on the recurrence in NBIMT is poorly investigated and understood.Aim: The aim of the study was to evaluate the impact of age and sex on the recurrence of non-muscle invasive bladder cancer.Materials and methods: Patients treated with transurethral resection (TUR) of primary NMIBT were included in the study. Risk calculation was made according to the European Organization for Research and Treatment of Cancer (EORTC) risk tables. Prognostic factors for predicting tumor recurrence up to 5 years including age and sex were analyzed. The Mann-Whitney U test was used for comparison of non-parametric variables in independent groups. Kaplan-Meier method, with log rank (Mantel-Cox) analyses applied for comparison of mean duration of remission by sex and age, was used to calculate mean duration of remission. Results: A total of 81 patients, 68 males (mean age 59.03 years) and 13 females (mean age 58.13 years) were eligible for final analysis. Mean survival time of patients <60 years old and older was 17.3±2.1 months (13.2–21.3) and 17.9±2.8 months (12.4–23.4), respectively (p=0.6). Mean survival time was 17.3±2.1 months for females and 15.4±2.1 months for males (p=0.08). However, 1-year tumor-free rate of female patients (53.8%) was not much different from that of males (31%) (p=0.11). Although considerable difference was observed between recurrence rates of patients according to sex, it failed to reach statistical significance.Conclusions: The results of the present study suggest that the recurrence of NMIBT is not associated with age or gender. 
first_indexed 2024-12-19T14:27:02Z
format Article
id doaj.art-3475760db7f041f198267657aaf95e01
institution Directory Open Access Journal
issn 1314-2143
language English
last_indexed 2024-12-19T14:27:02Z
publishDate 2021-04-01
publisher Pensoft Publishers
record_format Article
series Folia Medica
spelling doaj.art-3475760db7f041f198267657aaf95e012022-12-21T20:17:35ZengPensoft PublishersFolia Medica1314-21432021-04-0163224224610.3897/folmed.63.e5323453234Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancerHuseyin Kocan0Mustafa Kadihasanoglu1Gaziosmanpasa Training and Research HospitalIstanbul Training and Research HospitalIntroduction: Although demographic heterogeneity in the management of patients with non-muscle invasive bladder tumor (NMIBT) is an important factor, there are only minimal evidence-based recommendations that adjust for patient age and gender. The relationship and impact of age and gender on the recurrence in NBIMT is poorly investigated and understood.Aim: The aim of the study was to evaluate the impact of age and sex on the recurrence of non-muscle invasive bladder cancer.Materials and methods: Patients treated with transurethral resection (TUR) of primary NMIBT were included in the study. Risk calculation was made according to the European Organization for Research and Treatment of Cancer (EORTC) risk tables. Prognostic factors for predicting tumor recurrence up to 5 years including age and sex were analyzed. The Mann-Whitney U test was used for comparison of non-parametric variables in independent groups. Kaplan-Meier method, with log rank (Mantel-Cox) analyses applied for comparison of mean duration of remission by sex and age, was used to calculate mean duration of remission. Results: A total of 81 patients, 68 males (mean age 59.03 years) and 13 females (mean age 58.13 years) were eligible for final analysis. Mean survival time of patients <60 years old and older was 17.3±2.1 months (13.2–21.3) and 17.9±2.8 months (12.4–23.4), respectively (p=0.6). Mean survival time was 17.3±2.1 months for females and 15.4±2.1 months for males (p=0.08). However, 1-year tumor-free rate of female patients (53.8%) was not much different from that of males (31%) (p=0.11). Although considerable difference was observed between recurrence rates of patients according to sex, it failed to reach statistical significance.Conclusions: The results of the present study suggest that the recurrence of NMIBT is not associated with age or gender. https://foliamedica.bg/article/53234/download/pdf/agebladder tumorrecurrencesextransurethral
spellingShingle Huseyin Kocan
Mustafa Kadihasanoglu
Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer
Folia Medica
age
bladder tumor
recurrence
sex
transurethral
title Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer
title_full Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer
title_fullStr Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer
title_full_unstemmed Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer
title_short Age and sex do not affect first year recurrence in patients with non-muscle invasive bladder cancer
title_sort age and sex do not affect first year recurrence in patients with non muscle invasive bladder cancer
topic age
bladder tumor
recurrence
sex
transurethral
url https://foliamedica.bg/article/53234/download/pdf/
work_keys_str_mv AT huseyinkocan ageandsexdonotaffectfirstyearrecurrenceinpatientswithnonmuscleinvasivebladdercancer
AT mustafakadihasanoglu ageandsexdonotaffectfirstyearrecurrenceinpatientswithnonmuscleinvasivebladdercancer